Cerenome (CNSY) Cash from Investing Activities Growth (3y) (2013 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 46.78% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 66.14% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -44.69% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | -39.73% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | -246.81% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -53.57% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 27.84% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | 688.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 688.28% |
| Mar 31, 2026 | -344.74% |
| Dec 31, 2025 | -360.90% |
| Sep 30, 2025 | 245.67% |
| Jun 30, 2025 | -222.57% |
| Mar 31, 2025 | 101.38% |
| Dec 31, 2024 | 217.48% |
| Sep 30, 2024 | -31.04% |
| Jun 30, 2024 | -883.91% |
| Mar 31, 2024 | -63.03% |
| Dec 31, 2023 | 9.14% |
| Sep 30, 2023 | 10.61% |
| Jun 30, 2023 | 70.11% |
| Mar 31, 2023 | -106.60% |
| Dec 31, 2022 | 42.87% |
| Sep 30, 2022 | -154.58% |
| Jun 30, 2022 | -26.50% |
| Mar 31, 2022 | -358.15% |
| Dec 31, 2021 | 33.89% |
| Sep 30, 2021 | 56.91% |